1245.36.20052 Boehringer Ingelheim Investigational Site

Calgary, Alberta

0 studies enrolling now · 1 studies all time

What they study most

Diabetes Mellitus, Type 2, Renal Insufficiency

Studies at this site

• Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment — Completed